$HUM

Why Medicare Advantage is Exiting Minnesota Counties in 2027

Six Minnesota health insurers, including Humana, will exit Medicare Advantage (MA) plans in dozens of counties in 2027, affecting hundreds of thousands of residents. The exits are due to federal reimbursement cuts, rising pharmacy costs, increased healthcare utilization, and the Inflation Reduction Act's drug price cap. Insurers are exiting less profitable markets, with MA plans generating no profit, according to industry experts.

Original reporting
Published Oct 15, 2026, 2:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Medicare Advantage is Exiting Minnesota Counties in 2027 — source image
Decision brief

The 30-second read

$HUMBearishMed
01

Why it matters

The collective pullout reflects systemic profitability challenges in the MA market, possibly prompting further exits.

02

Market read

Sector‑wide pressure on MA insurers could influence stock performance of publicly traded health insurers.

03

What to watch

Potential cost savings from exiting low-margin counties may offset revenue loss.

Relevance 5/10Novelty 5/10Timing: effective 2027

Background

Medicare Advantage plans are reimbursed at the county level; recent CMS reimbursement cuts and drug price caps have squeezed margins.

Company-level read

Ticker impact

$HUMBearishHigh confidence
Context

Humana announced it will exit Minnesota's Medicare Advantage market entirely, part of the broader insurer pullout.

Expected impact

likely pressure as investors price in loss of Minnesota MA business.

Evidence & confidence

The exit removes a geographic segment, reducing future premium volume.

Market effects

Signals broader pressure on Medicare Advantage insurers, may affect other regional players.

Minnesota health insurance market faces reduced competition and potential premium changes.

Limited to U.S. Medicare Advantage sector.

Counterpoint

Some investors may view the exit as a strategic retreat that could improve profitability elsewhere.

Key entities

  • Humana

    U.S.-listed health insurer exiting Minnesota MA market.

  • Blue Cross and Blue Shield of Minnesota

    State insurer facing $500M loss on Original Medicare expenses.

Related articles

$HUMMed

Humana’s $2.8 bn BlackRock deal follows Medicare Advantage ratings recovery

Humana (HUM) agreed to a $2.8 bn deal with BlackRock, restructuring ownership of 150 CenterWell clinics. BlackRock acquires WCAS's majority stake, with Humana retaining minority ownership. The deal reduces Humana's balance sheet obligations. Humana's Medicare Advantage star ratings improved, potentially increasing 2028 bonus payments to $4.8 bn, per Evercore ISI. S&P affirmed Humana's BBB rating but maintained a negative outlook.

$HUMMedAI 9/10

Seniors at About 150 CenterWell Clinics Face New Majority Owner as BlackRock Replaces Private Equity Backer

Humana announced that BlackRock's HPS Investment Partners will acquire Welsh Carson's stake in about 150 CenterWell clinics, valued at $2.8B. The deal, expected to close in Q4 2026, will make BlackRock the majority owner, with CenterWell retaining a minority stake and operational control. Humana stated patient care will remain unchanged, and the deal is not expected to materially affect its 2026 earnings guidance.

$HUMMedAI 8/10

Humana, BlackRock Strike $2.8 Bn Deal for CenterWell Clinics

Humana and BlackRock's HPS Investment Partners will form a joint venture to operate and expand CenterWell clinics, with BlackRock acquiring WCAS's stake for $2.8B. The deal aims to provide growth capital and lower costs for Humana, with no disruption to patient care. Humana may repurchase clinics starting 2028. The transaction is expected to close in Q4 2026, with no impact on 2026 earnings guidance.

$HUMMed

What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care

Humana (NYSE: HUM) announced a joint venture with BlackRock to manage 150 CenterWell clinics, while Village Medical divested 27 clinics to Harbor Health. These moves suggest a shift in the senior-focused primary care industry, with changes in ownership and financing strategies. Humana's deal includes a $2.8 billion equity acquisition and potential clinic purchases by CenterWell starting in 2028.

$HUMMedAI 8/10

Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital

Humana (HUM) is forming a joint venture with BlackRock to own 150 CenterWell clinics, valued at $2.8B. BlackRock will hold majority ownership, with Humana retaining minority. The deal, expected to close in Q4 2026, will reduce Humana's liabilities and support clinic expansion. Humana's 2026 earnings guidance remains at least $9 per share.

$ANGOMed

AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer

AngioDynamics announced that Humana updated its Medicare Advantage coverage policy to include NanoKnife IRE for prostate and liver cancer, effective October 1, 2026. This follows recent reimbursement milestones, including new CPT codes and Palmetto GBA's LCD L40205. Humana, with 7 million members, will use LCD L40205 criteria for coverage, subject to prior authorization.